Mercodia’s quest for growth included defining and entering new markets. To determine the expansion potential without compromising product and service quality, the company asked BearingPoint for an evidence-based approach revealing the existing needs. As a result of BearingPoint’s engagement, Mercodia decided to pursue a new market.
Mercodia was looking to investigate and assess new markets to achieve growth while maintaining product and service quality standards at their renowned high level, that has positioned them as a trusted brand on the Biotech market. Challenged with extended time to market due to extensive regulatory and quality demands, Mercodia needed a structured, evidence-based approach to evaluate potential markets that met their growth requirements.
BearingPoint created a cross-functional team of subject matter experts in academic research, medicine and life science knowledge and experts in strategic projects. Leveraging the Ansoff matrix, they organized workshops using an outside-in approach and an evidence-driven analysis of new disease areas. This resulted in a limited number of areas and markets. To reduce this number, they made a selection criteria framework tailored to fit the bio-tech industry and meet Mercodia’s requirements. Key opinion leaders in clinical trials were then interviewed to prepare a detailed competitive landscape.
Based on the BearingPoint contribution, Mercodia decided to pursue a new research market. BearingPoint’s assistance helped Mercodia obtain sufficient information and data to convince them to support a new research market leading to market differentiation and potential growth.
Founded in 1991 as a privately-owned biotech company, Mercodia is a world-leading developer, manufacturer and distributor of high-quality immunoassay kits for the measurement of biomarkers in the areas of diabetes, obesity and cardiovascular disease.
BearingPoint worked with the client to create a customized solution for an effective order management workflow. The new cloud-based platform allowed the client to simplify and automate its ordering process, to respond to changing market needs with flexibility and offer data driven insights to improve production planning and patient care.
Read more
With BearingPoint’s help, one of the world’s largest healthcare companies fully transformed its global business model by improving its IT operations performance and efficiency. This resulted in making IT processes consistent across all locations, leading to more agile and flexible ways of delivering services to the business, and enabling the company to quickly address new market opportunities and accelerate digital growth.
Read more
Pharmaceutical products must comply with strict regulations before they can enter the market. Part of this procedure involves making sure that storage conditions ensure maximum safety, efficacy, and quality of medications. By leveraging a robotic process automation solution (RPA), BearingPoint helped Boehringer Ingelheim to increase accuracy and minimize the risk of human error in determining the medications' storage requirements.
Read more
BearingPoint conducted a structured, evidence-based approach to evaluate potential markets that met Mercodias growth requirements. As a result, they decided to pursue a new market.
Read more